BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Bot Chart, page-14870

  1. 42 Posts.
    lightbulb Created with Sketch. 11
    should not discount profit margins here.....from analyst reports and with product such as this, it looks like margins will be sitting around ~40% EBITDA margin.....that is massive. I know there is a lot of ifs and buts, but if sales go ballistic and start to penetrate 2%, 5%, 10% of the market - we have all done the maths on what that works out to be $$$. sustain those sales figures for an extensive period and generate EBITDA profit at these level indicated - there is sufficient funds for developing current pipeline, M&A activity and dividends.

    BoT has all the gears to be a major player in the industry in 5-7 years.
    ou are returning back 10
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.